News

26.3.: Gastvortrag: Microbial-based Treatments of Allergy and Asthma

Barrierefreiheit: Kurzbeschreibung des Bildes
Foto: Liam O’Mahony, PD, Ph.D., ist Leiter der Forschungsgruppe Molecular Immunology am Swiss Institute of Allergy and Asthma Research (SIAF) der Universität Zürich, Davos, Schweiz.
Abstract:
The mucosal immune system is in constant communication with the vast diversity of microbes present on body surfaces. The discovery of novel molecular mechanisms, which mediate host-microbe communication, have highlighted the important roles played by microbes in influencing mucosal immune responses. Dendritic cells, epithelial cells, ILCs, T regulatory cells, effector lymphocytes, NKT cells and B cells can all be influenced by the microbiome.
Many of the mechanisms being described are bacterial strain- or metabolite-specific. Microbial dysbiosis in the gut and the lung is increasingly being associated with the incidence and severity of asthma. More accurate endotyping of patients with asthma may be assisted by further analysis of the composition and metabolic activity of an individual’s microbiome. In addition, the efficacy of specific therapeutics may be influenced by the microbiome and novel bacterial-based therapeutics should be considered in future clinical studies.

Einladung GV OMahony

Weiss Richard, Assoz. Prof. Dr.

Co-Head of "Gene Vaccines"

Universität Salzburg

Hellbrunnerstrasse 34

Tel: +43 662 8044 5737

E-Mail an Weiss Richard, Assoz. Prof. Dr.